Zobrazeno 1 - 10 of 46 pro vyhledávání: '"JEREMIE LEBREC"'
1
Akademický článek
Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study
Autor: Alan Lenox-Smith, Catherine Reed, Jeremie Lebrec, Mark Belger, Roy W. Jones
Publikováno v: BMC Geriatrics, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Given the high costs associated with the care of those with Alzheimer’s disease (AD) dementia, we examined the likely impact of a reduction in the rate of cognitive decline upon cost outcomes associated with this disease. Method
Externí odkaz: https://doaj.org/article/a07e3ffae08741d1b055cd7586adcca5
Zobrazit plný text záznamu
2
Akademický článek
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
Autor: Roy W. Jones, Jeremie Lebrec, Kristin Kahle-Wrobleski, Grazia Dell’Agnello, Giuseppe Bruno, Bruno Vellas, Josep M. Argimon, Richard Dodel, Josep Maria Haro, Anders Wimo, Catherine Reed
Publikováno v: Dementia and Geriatric Cognitive Disorders Extra, Vol 7, Iss 1, Pp 87-100 (2017)
Background/Aims: We assessed whether cognitive and functional decline in community-dwelling patients with mild Alzheimer disease (AD) dementia were associated with increased societal costs and caregiver burden and time outcomes. Methods: Cognitive de
Externí odkaz: https://doaj.org/article/998bca5a2ab84132ac7d6f7adba0d269
Zobrazit plný text záznamu
3
Akademický článek
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
Autor: Alan Lenox-Smith, Catherine Reed, Jeremie Lebrec, Mark Belger, Roy W. Jones
Publikováno v: BMC Geriatrics, Vol 16, Iss 1, Pp 1-10 (2016)
Abstract Background Alzheimer’s disease (AD), the commonest cause of dementia, represents a significant cost to UK society. This analysis describes resource utilisation, costs and clinical outcomes in non-institutionalised patients with AD in the U
Externí odkaz: https://doaj.org/article/b1c32d6459dd493ba82dffd40ed6ade6
Zobrazit plný text záznamu
4
Akademický článek
Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study
Autor: Alonso Montoya, Jeremie Lebrec, Karen Mary Keane, Irene Fregenal, Antonio Ciudad, Ángel Moríñigo, Luis Agüera-Ortiz, Irene Romera, Inmaculada Gilaberte, Mark Zimmerman
Publikováno v: BMC Psychiatry, Vol 16, Iss 1, Pp 1-11 (2016)
Abstract Background Goals of treating major depressive disorder (MDD) include achieving remission and avoiding relapse. It is possible that patients may have a broader view of remission than what is captured via clinician-rated scales. This patient p
Externí odkaz: https://doaj.org/article/b89a2efbdbb54ec49f2ea86b79f35d0a
Zobrazit plný text záznamu
9
Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain
Autor: Santiago Tofé-Povedano, A Sicras-Mainar, Irene Romera, Silvia Díaz, Kirsi Norrbacka, Esther Artime, Ignacio Hernández, Jeremie Lebrec
Publikováno v: Diabetes Therapy
Introduction This study aimed to describe utilization patterns, persistence, resource utilization and costs in patients with type 2 diabetes mellitus initiating treatment with glucagon-like peptide 1 receptor agonists in routine clinical practice in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2c62478affc9fadc46295afb049c522
http://europepmc.org/articles/PMC8099971
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje